Biotech Values

[mcbio]

Question RE MNTA generic competition

Dew or others:

Are the FDA decisions for Teva, Amphastar, and MNTA's generic drugs for Lovenox all mutually exclusive in terms of timing or are the decisions expected to be known around the same time for all three? If mutually exclusive, which company is first expected to get an FDA decision and is there any idea of timing in 2009?

Also, in the ReadMeFirst, there is discussion that Craig Wheeler believes that Amphastar is not close to approval for their generic. Are Teva and Amphastar two separate competitors or just one joint entity? If they're separate, what do we know about Teva's generic and any reasons why it would be unlikely to receive approval?